J
Johan Mårtensson
Researcher at Karolinska Institutet
Publications - 125
Citations - 3878
Johan Mårtensson is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Intensive care & Acute kidney injury. The author has an hindex of 26, co-authored 111 publications receiving 2866 citations. Previous affiliations of Johan Mårtensson include Karolinska University Hospital & Umeå University.
Papers
More filters
Journal ArticleDOI
The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.
Michael Haase,Prasad Devarajan,Anja Haase-Fielitz,Rinaldo Bellomo,Dinna N. Cruz,Gebhard Wagener,Catherine D. Krawczeski,Jay L. Koyner,Patrick T. Murray,Michael Zappitelli,Stuart L. Goldstein,Konstantinos Makris,Claudio Ronco,Johan Mårtensson,Claes-Roland Martling,Per Venge,Edward D. Siew,Lorraine B. Ware,T. Alp Ikizler,Peter R. Mertens +19 more
TL;DR: In the absence of diagnostic increases in serum creatinine, NGAL detects patients with likely subclinical AKI who have an increased risk of adverse outcomes and the concept and definition of AKI might need re-assessment.
Journal ArticleDOI
Acute kidney injury in sepsis.
Rinaldo Bellomo,John A. Kellum,Claudio Ronco,Ron Wald,Ron Wald,Johan Mårtensson,Matthew J Maiden,Matthew J Maiden,Sean M. Bagshaw,Neil J Glassford,Neil J Glassford,Yugeesh R Lankadeva,Suvi T. Vaara,Antoine G. Schneider +13 more
TL;DR: In this paper, the optimal intensity of renal replacement therapy has been established, while the timing of when to commence RRT is now a focus of investigation, as well as when to start RRT in patients with septic AKI.
Journal ArticleDOI
Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury.
TL;DR: In this paper, the authors study the impact of inflammation/sepsis on the concentrations of neutrophil gelatinase-associated lipocalin (NGAL) in plasma and urine in adult ICU patients and estimate the predictive properties of NGAL for early detection of acute kidney injury (AKI) in patients with septic shock.
Journal ArticleDOI
Novel biomarkers of acute kidney injury and failure: clinical applicability.
TL;DR: Novel biomarkers of AKI- and failure include neutrophil gelatinase-associated lipocalin, N-acetyl-β-d-glucosaminidase, kidney injury molecule-1, interleukin-18, and cystatin C, which may have clinical applicability in anaesthesia and intensive care in the future.
Journal ArticleDOI
Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial).
Glenn M Eastwood,Antoine G. Schneider,Satoshi Suzuki,Leah Peck,Helen Young,Aiko Tanaka,Johan Mårtensson,Stephen J Warrillow,Shay McGuinness,Rachael Parke,Eileen Gilder,Lianne McCarthy,Pauline Galt,Gopal Taori,Suzanne Eliott,Tammy Lamac,Michael Bailey,Nerina Harley,Deborah Barge,Carol L. Hodgson,Maria Cristina Morganti-Kossmann,Maria Cristina Morganti-Kossmann,Alice Pébay,Alison Conquest,John S. Archer,Stephen Bernard,Dion Stub,Graeme K Hart,Rinaldo Bellomo +28 more
TL;DR: In CA patients admitted to the ICU, TTMH was feasible, appeared safe and attenuated the release of NSE compared with TN, and these findings justify further investigation of this novel treatment.